- Home
- APLS vs PBH Comparison
APLS vs PBH Comparison
Compare APLS & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- PBH
- Stock Information
- Founded
- APLS 2009
- PBH 1996
- Country
- APLS United States
- PBH United States
- Employees
- APLS N/A
- PBH N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- PBH Biotechnology: Pharmaceutical Preparations
- Sector
- APLS Health Care
- PBH Health Care
- Exchange
- APLS Nasdaq
- PBH Nasdaq
- Market Cap
- APLS 3.5B
- PBH 3.3B
- IPO Year
- APLS 2017
- PBH 2005
- Fundamental
- Price
- APLS $25.17
- PBH $63.75
- Analyst Decision
- APLS Buy
- PBH Buy
- Analyst Count
- APLS 20
- PBH 5
- Target Price
- APLS $34.11
- PBH $94.00
- AVG Volume (30 Days)
- APLS 2.1M
- PBH 583.0K
- Earning Date
- APLS 11-04-2025
- PBH 11-06-2025
- Dividend Yield
- APLS N/A
- PBH N/A
- EPS Growth
- APLS N/A
- PBH 4.18
- EPS
- APLS N/A
- PBH 4.26
- Revenue
- APLS $754,649,000.00
- PBH $1,120,150,000.00
- Revenue This Year
- APLS $20.59
- PBH N/A
- Revenue Next Year
- APLS N/A
- PBH $2.24
- P/E Ratio
- APLS N/A
- PBH $15.29
- Revenue Growth
- APLS 20.02
- PBH 0.63
- 52 Week Low
- APLS $16.10
- PBH $62.95
- 52 Week High
- APLS $39.51
- PBH $90.04
- Technical
- Relative Strength Index (RSI)
- APLS 44.82
- PBH 33.56
- Support Level
- APLS $27.26
- PBH $64.38
- Resistance Level
- APLS $28.97
- PBH $66.04
- Average True Range (ATR)
- APLS 0.99
- PBH 1.45
- MACD
- APLS -0.58
- PBH 0.17
- Stochastic Oscillator
- APLS 11.00
- PBH 2.82
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.